Early prediction of response to neoadjuvant chemotherapy in patients with breast cancer using diffusion-weighted imaging and gray-scale ultrasonography

Oncology Reports

Volumn 31, Issue 4, 2014, Pages 1555-1560

  Iwasa, Hitomi ^a   Kubota, Kei ^a   Hamada, Norihiko ^a   Nogami, Munenobu ^a   Nishioka, Akihito ^a  

^a KOCHI UNIVERSITY   (Japan)

Author keywords

Breast; Cancer; Chemotherapy; Diffusion weighted imaging; Prediction; Response rate; Ultrasonography

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; GADOLINIUM PENTETATE;

ADULT; AGED; APPARENT DIFFUSION COEFFICIENT; AREA UNDER THE CURVE; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION COEFFICIENT; FEMALE; GRAY SCALE ECHOGRAPHY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; TUMOR VOLUME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DIFFUSION MAGNETIC RESONANCE IMAGING; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MIDDLE AGED; NEOADJUVANT THERAPY; TREATMENT OUTCOME;

EID: 84908131226     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3025     Document Type: Article

References (31)

1. Gralow JR, Burstein HJ, Wood W, Hortobagyi GN, Gianni L, von Minckwitz G, Buzdar AU, Smith IE, Symmans WF, Singh B and Winer EP: Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease. J Clin Oncol 26: 814-819, 2008.
2. Kaufmann M, Hortobagyi GN, Goldhirsch A, Scholl S, Makris A, Valagussa P, Blohmer JU, Eiermann W, Jackesz R, Jonat W, Lebeau A, Loibl S, Miller W, Seeber S, Semiglazov V, Smith R, Souchon R, Stearns V, Untch M and von Minckwitz G: Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update. J Clin Oncol 24: 1940-1949, 2006.
3. Ogawa Y, Nishioka A, Inomata T, Tsuboi N, Hayase N, Fukumoto M, Yoshida S, Tohchika N, Tanaka Y and Kumon M: Conservation treatment intensified with tamoxifen and CAF chemotherapy for subareolar breast cancers. Oncol Rep 5: 1337-1341, 1998.
4. Ogawa Y, Nishioka A, Inomata T, Yokota N, Sasaki T, Terashima M, Yoshida S, Tanaka Y and Tohchika N: Conservation treatment intensified with tamoxifen and CAF chemotherapy without axillary dissection for early breast cancer patients with clinically-negative axillary nodes. Oncol Rep 6: 801-805, 1999.
5. van der Hage JA, van de Velde CJ, Julien JP, Tubiana-Hulin M, Vandervelden C and Duchateau L: Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol 19: 4224-4237, 2001.
6. Rastogi P, Anderson SJ, Bear HD, et al: Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol 26: 778-785, 2008.
7. Guarneri V, Frassoldati A, Giovannelli S, Borghi F and Conte P: Primary systemic therapy for operable breast cancer: a review of clinical trials and perspectives. Cancer Lett 248: 175-185, 2007.
8. Sachelarie I, Grossbard ML, Chadha M, Feldman S, Ghesani M and Blum RH: Primary systemic therapy of breast cancer. Oncologist 11: 574-589, 2006.
9. Kim T, Murakami T, Takahashi S, Hori M, Tsuda K and Nakamura H: Diffusion-weighted single-shot echoplanar MR imaging for liver disease. AJR Am J Roentgenol 173: 393-398, 1999.
10. Koh DM, Scurr E, Collins D, et al: Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients. AJR Am J Roentgenol 188: 1001-1008, 2007.
11. Kubota K, Yamanishi T, Itoh S, Murata Y, Miyatake K, Yasunami H, Morio K, Hamada N, Nishioka A and Ogawa Y: Role of diffusion-weighted imaging in evaluating therapeutic efficacy after transcatheter arterial chemoembolization for hepatocellular carcinoma. Oncol Rep 24: 727-732, 2010.
12. Pickles MD, Gibbs P, Lowry M and Turnbull LW: Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging 24: 843-847, 2006.
13. Yankeelov TE, Lepage M, Chakravarthy A, Broome EE, Niermann KJ, Kelley MC, Meszoely I, Mayer IA, Herman CR, McManus K, Price RR and Gore JC: Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. Magn Reson Imaging 25: 1-13, 2007.
14. Murata Y, Kubota K, Hamada N, Miyatake K, Tadokoro M, Nakatani K, Ue H, Tsuzuki K, Nishioka A, Iguchi M, Maeda H and Ogawa Y: Diffusion-weighted magnetic resonance imaging for assessment after neoadjuvant chemotherapy in breast cancer, based on morphological concepts. Oncol Lett 1: 293-298, 2010.
15. Park SH, Moon WK, Cho N, Song IC, Chang JM, Park IA, Han W and Noh DY: Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer. Radiology 257: 56-63, 2010.
16. Fangberget A, Nilsen LB, Hole KH, Holmen MM, Engebraaten O, Naume B, Smith HJ, Olsen DR and Seierstad T: Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging. Eur Radiol 21: 1188-1199, 2011.
17. Shin HJ, Baek HM, Ahn JH, Baek S, Kim H, Cha JH and Kim HH: Prediction of pathologic response to neoadjuvant chemotherapy in patients with breast cancer using diffusion-weighted imaging and MRS. NMR Biomed 25: 1349-1359, 2012.
18. Richard R, Thomassin I, Chapellier M, Scemama A, de Cremoux P, Varna M, Giacchetti S, Espié M, de Kerviler E and de Bazelaire C: Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer. Eur Radiol 23: 2420-2431, 2013.
19. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC and Gwyther SG: New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92: 205-216, 2000.
20. Raza S and Baum JK: Solid breast lesions: evaluation with power Doppler US: Radiology 203: 164-168, 1997.
21. Raza S, Chikarmane SA, Neilsen SS, Zorn LM and Birdwell RL: BI-RADS 3, 4, and 5 lesions: value of US in management - follow-up and outcome. Radiology 248: 773-781, 2008.
22. Kubota K, Iwasa H, Aoyama N, Hamada N, Nogami M, Tamura T, Nishioka A and Ogawa Y: Power Doppler and gray-scale sonography standardized by BI-RADS for the differentiation of benign postoperative lesion and local recurrence after breast-conserving therapy. Oncol Rep 26: 1357-1362, 2011.
23. Satake H, Shimamoto K, Sawaki A, Niimi R, Ando Y, Ishiguchi T, Ishigaki T, Yamakawa K, Nagasaka T and Funahashi H: Role of ultrasonography in the detection of intraductal spread of breast cancer: correlation with pathologic findings, mammography and MR imaging. Eur Radiol 10: 1726-1732, 2000.
24. Kubota K, Ogawa Y, Nishigawa T and Yoshida S: Tissue harmonic imaging sonography of the axillary lymph nodes: Evaluation of response to neoadjuvant chemotherapy in breast cancer patients. Oncol Rep 10: 1911-1914, 2003.
25. Kubota K, Ogawa Y, Nishioka A, Kariya S, Itoh S, Murata Y, Hamada N, Maeda H and Tanaka Y: Diagnostic accuracy of mammography, ultrasonography and magnetic resonance imaging in the detection of intraductal spread of breast cancer following neoadjuvant chemotherapy. Oncol Rep 17: 915-918, 2007.
26. Kubota K, Ogawa Y, Nishioka A, Murata Y, Itoh S, Hamada N, Morio K, Maeda H and Tanaka Y: Radiological imaging features of invasive micropapillary carcinoma of the breast and axillary lymph nodes. Oncol Rep 20: 1143-1147, 2008.
27. Hitomi J, Kubota K, Ogawa Y, Hamada N, Murata Y and Nishioka A: Non-surgical therapy and radiologic assessment of stage I breast cancer treatment with novel enzyme-targeting radiosensitization: Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, type II (KORTUC II). Exp Ther Med 1: 769-775, 2010.
28. Miyatake K, Kubota K, Ogawa Y, Hamada N, Murata Y and Nishioka A: Non-surgical care for locally advanced breast cancer: Radiologically assessed therapeutic outcome of a new enzyme-targeting radiosensitization treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II) with systemic chemotherapy. Oncol Rep 24: 1161-1168, 2010.
29. Murata Y, Ogawa Y, Yoshida S, Kubota K, Itoh S, Fukumoto M, Nishioka A, Moriki T, Maeda H and Tanaka Y: Utility of initial MRI for predicting extent of residual disease after neoadjuvant chemotherapy: Analysis of 70 breast cancer patients. Oncol Rep 12: 1257-1262, 2004.
30. Murata Y, Hamada N, Kubota K, Miyatake K, Tadokoro M, Kataoka Y, Ue H, Tsuzuki K, Kariya S, Nishioka A and Ogawa Y: Choline by magnetic spectroscopy and dynamic contrast enhancement curve by magnetic resonance imaging in neoadjuvant chemotherapy for invasive breast cancer. Mol Med Rep 2: 39-43, 2009.
31. Garcia Garcia-Esquinas MA, Arrazola Garcia J, Garcia-Saenz JA, Furio-Bacete V, Fuentes Ferrer ME, Ortega Candil A, Cabrera Martin MN and Carreras Delgado JL: Predictive value of PET-CT for pathological response in stages II and III breast cancer patients following neoadjuvant chemotherapy with docetaxel. Rev Esp Med Nucl Imagen Mol: Jun 25, 2013 (Epub ahead of print). doi: 10.1016/j.remn.2013.04.008.